Correlation Between Suzhou Novoprotein and Double Medical

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Double Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Double Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Double Medical Technology, you can compare the effects of market volatilities on Suzhou Novoprotein and Double Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Double Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Double Medical.

Diversification Opportunities for Suzhou Novoprotein and Double Medical

0.94

Correlation Coefficient

Suzhou Novoprotein  Double Medical

Almost no diversification

The 3 months correlation between Suzhou and Double is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Double Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Double Medical Technology and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Double Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Double Medical Technology has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Double Medical go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Double Medical

Assuming the 90 days trading horizon Suzhou Novoprotein is expected to generate 1.64 times less return on investment than Double Medical. In addition to that, Suzhou Novoprotein is 1.06 times more volatile than Double Medical Technology. It trades about 0.11 of its total potential returns per unit of risk. Double Medical Technology is currently generating about 0.2 per unit of volatility. If you would invest  2,398  in Double Medical Technology on September 3, 2024 and sell it today you would earn a total of  879.00  from holding Double Medical Technology or generate 36.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Double Medical Technology

Suzhou Novoprotein

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Double Medical Technology

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Double Medical Technology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Double Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Suzhou Novoprotein and Double Medical

The main advantage of trading using opposite Suzhou Novoprotein and Double Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Double Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Double Medical will offset losses from the drop in Double Medical's long position.

The idea behind Suzhou Novoprotein Scientific and Double Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.